Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.4 has been added, replacing the prior Revision: v3.5.3. This indicates a version update to the page content.SummaryDifference0.1%

- Check13 days agoChange DetectedMelanoma is no longer listed as a topic on the study page, and the MedlinePlus Genetics related topics link has been removed. This reduces the visible disease context and external resource navigation associated with the melanoma vaccine trial.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page metadata now includes Melanoma as a disease keyword and a Related topics section with MedlinePlus Genetics, and the revision tag has been updated from v3.5.2 to v3.5.3.SummaryDifference0.2%

- Check27 days agoChange DetectedRemoved the “Melanoma” related topics and associated MedlinePlus Genetics link from the page.SummaryDifference0.2%

- Check34 days agoChange DetectedAdded a new site revision entry for v3.5.2. Removed the previous entry for v3.5.0.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the study page.SummaryDifference0.2%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.